---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-030651"
form_type: "8-K"
ticker: "EDSA"
cik: "0001540159"
company_name: "Edesa Biotech, Inc."
filed_at: "2022-03-04T23:59:59+00:00"
generated_at: "2026-06-27T01:34:19.296303+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Edesa Biotech amends equity distribution agreement with RBC for up to $15.4M ATM

## Summary
- Amended Equity Distribution Agreement with RBC Capital Markets to sell up to $15.4M additional common shares.
- Previously sold 487,228 shares for $2.5M under the prior agreement.
- Amendment enables ongoing at-the-market offerings through RBC as sales agent or principal.
- Legal opinion from Fasken Martineau DuMoulin LLP regarding share legality attached as exhibit.

## SEC filing metadata
- accession: 0001104659-22-030651
- form_type: 8-K
- ticker: EDSA
- cik: 0001540159
- company_name: Edesa Biotech, Inc.
- filed_at: 2022-03-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1540159/000110465922030651/0001104659-22-030651-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1540159/000110465922030651/tm228418d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-030651
- JSON: https://secwatch.observer/filing/0001104659-22-030651.json
- Plain text: https://secwatch.observer/filing/0001104659-22-030651.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.